Loading...

Upexi, Inc.

GRVI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.95
$0.35(7.61%)

Upexi, Inc. (GRVI) Stock Overview

Explore Upexi, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.0/100

Key Financials

Market Cap88.9M
P/E Ratio19.82
EPS (TTM)$0.19
ROE0.28%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.51

GRVI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Upexi, Inc. (GRVI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.82 and a market capitalization of 88.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;